US Stock MarketDetailed Quotes
CANF Can-Fite BioPharma
- 1.9258
- -0.0242-1.24%
Trading Oct 2 10:39 ET
11.74MMarket Cap-740P/E (TTM)
1.9500High1.9258Low5.31KVolume1.9500Open1.9500Pre Close10.31KTurnover0.09%Turnover RatioLossP/E (Static)6.10MShares4.690052wk High4.73P/B11.74MFloat Cap1.810052wk Low--Dividend TTM6.10MShs Float1419.0000Historical High--Div YieldTTM1.24%Amplitude1.5200Historical Low1.9420Avg Price1Lot Size
Can-Fite BioPharma Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -50.83%4.73M | 11.71%8.92M | 11.71%8.92M | -26.55%7.94M | -24.67%9.62M | -25.66%12.42M | -58.27%7.99M | -58.27%7.99M | -20.86%10.81M | 63.50%12.77M |
| -Cash and cash equivalents | 36.47%4.72M | 43.65%4.28M | 43.65%4.28M | -9.23%3.38M | 101.99%3.46M | -77.03%1.26M | -32.16%2.98M | -32.16%2.98M | -35.81%3.73M | 67.02%1.71M |
| -Short-term investments | -99.85%9K | -7.29%4.64M | -7.29%4.64M | -35.66%4.56M | -44.29%6.16M | -0.40%11.15M | -66.04%5.01M | -66.04%5.01M | -9.81%7.09M | 62.97%11.05M |
| Other current assets | -14.93%1.1M | -15.73%986K | -15.73%986K | -35.96%1.12M | -29.07%1.29M | -0.93%962K | 25.94%1.17M | 25.94%1.17M | 116.03%1.75M | 4.47%1.82M |
| Total current assets | -46.58%5.83M | 8.20%9.91M | 8.20%9.91M | -27.86%9.06M | -25.22%10.91M | -24.30%13.38M | -54.37%9.16M | -54.37%9.16M | -13.19%12.57M | 52.72%14.59M |
| Non current assets | ||||||||||
| Net PPE | -23.58%94K | -35.71%81K | -35.71%81K | -25.53%105K | -21.66%123K | -36.78%110K | -31.89%126K | -31.89%126K | -14.55%141K | 23.62%157K |
| -Gross PPE | -23.58%94K | -8.02%344K | -8.02%344K | -25.53%105K | -21.66%123K | -36.78%110K | -10.74%374K | -10.74%374K | -14.55%141K | 23.62%157K |
| -Accumulated depreciation | ---- | -6.05%-263K | -6.05%-263K | ---- | ---- | ---- | -5.98%-248K | -5.98%-248K | ---- | ---- |
| Total non current assets | -23.58%94K | -35.71%81K | -35.71%81K | -25.53%105K | -21.66%123K | -36.78%110K | -31.89%126K | -31.89%126K | -14.55%141K | 23.62%157K |
| Total assets | -46.32%5.92M | 7.61%9.99M | 7.61%9.99M | -27.84%9.17M | -25.19%11.03M | -24.42%13.49M | -54.16%9.28M | -54.16%9.28M | -13.20%12.71M | 52.33%14.75M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | -6.47%1.32M | -52.34%427K | -52.34%427K | -27.82%1.39M | 9.16%1.41M | 1.72%2.07M | -6.08%896K | -6.08%896K | 73.72%1.93M | -1.98%1.29M |
| -accounts payable | 9.26%885K | -52.34%427K | -52.34%427K | -56.05%647K | -1.70%810K | -14.32%963K | -6.08%896K | -6.08%896K | 82.63%1.47M | -18.01%824K |
| -Other payable | -27.85%430K | ---- | ---- | 62.88%746K | 28.45%596K | 21.61%1.1M | ---- | ---- | 50.16%458K | 50.16%464K |
| Current accrued expenses | ---- | -11.66%250K | -11.66%250K | ---- | ---- | ---- | -6.29%283K | -6.29%283K | ---- | ---- |
| Current debt and capital lease obligation | -18.18%36K | -43.75%27K | -43.75%27K | -29.17%34K | -6.38%44K | -23.64%42K | -9.43%48K | -9.43%48K | 20.00%48K | 9.30%47K |
| -Current capital lease obligation | -18.18%36K | -43.75%27K | -43.75%27K | -29.17%34K | -6.38%44K | -23.64%42K | -9.43%48K | -9.43%48K | 20.00%48K | 9.30%47K |
| Current deferred liabilities | -18.77%636K | -20.56%622K | -20.56%622K | -4.28%783K | -4.28%783K | -4.28%783K | -4.28%783K | -4.28%783K | -18.36%818K | -18.36%818K |
| Current liabilities | -11.02%1.99M | -19.26%2.02M | -19.26%2.02M | -20.96%2.21M | 3.72%2.23M | -0.45%2.89M | -8.35%2.5M | -8.35%2.5M | 29.87%2.8M | -8.73%2.15M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | -4.55%21K | -7.14%13K | -7.14%13K | -34.62%17K | -45.00%22K | -88.89%6K | -80.28%14K | -80.28%14K | -58.06%26K | 60.00%40K |
| -Long term capital lease obligation | -4.55%21K | -7.14%13K | -7.14%13K | -34.62%17K | -45.00%22K | -88.89%6K | -80.28%14K | -80.28%14K | -58.06%26K | 60.00%40K |
| Non current deferred liabilities | -24.59%1.44M | -25.36%1.71M | -25.36%1.71M | -30.50%1.71M | -28.49%1.9M | -26.74%2.1M | -25.24%2.3M | -25.24%2.3M | -20.52%2.46M | -20.35%2.66M |
| Total non current liabilities | -24.36%1.46M | -25.25%1.73M | -25.25%1.73M | -30.54%1.72M | -28.73%1.93M | -27.89%2.11M | -26.49%2.31M | -26.49%2.31M | -21.26%2.48M | -19.76%2.7M |
| Total liabilities | -17.20%3.44M | -22.14%3.75M | -22.14%3.75M | -25.46%3.93M | -14.34%4.16M | -14.20%5M | -18.05%4.81M | -18.05%4.81M | -0.51%5.28M | -15.21%4.85M |
| Shareholders'equity | ||||||||||
| Share capital | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | 38.75%60.65M | 63.89%60.65M |
| -common stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | 38.75%60.65M | 63.89%60.65M |
| Retained earnings | -4.75%-162.44M | -5.06%-158.48M | -5.06%-158.48M | -6.09%-156.83M | -6.72%-155.07M | -7.19%-153.4M | -7.23%-150.85M | -7.23%-150.85M | -10.35%-147.83M | -11.28%-145.3M |
| Paid-in capital | 1.85%163.79M | 6.10%163.6M | 6.10%163.6M | 72.17%160.94M | 72.16%160.81M | 72.21%160.76M | 0.17%154.19M | 0.17%154.19M | -5.06%93.48M | -3.09%93.41M |
| Gains losses not affecting retained earnings | 0.00%1.13M | 0.00%1.13M | 0.00%1.13M | 0.00%1.13M | 0.00%1.13M | 0.00%1.13M | 0.00%1.13M | 0.00%1.13M | 0.00%1.13M | 0.00%1.13M |
| Total stockholders'equity | -63.94%2.48M | 39.60%6.24M | 39.60%6.24M | -29.52%5.24M | -30.51%6.87M | -29.37%8.49M | -68.91%4.47M | -68.91%4.47M | -20.42%7.43M | 150.11%9.89M |
| Total equity | -63.94%2.48M | 39.60%6.24M | 39.60%6.24M | -29.52%5.24M | -30.51%6.87M | -29.37%8.49M | -68.91%4.47M | -68.91%4.47M | -20.42%7.43M | 150.11%9.89M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data